Literature DB >> 26323883

Improved survival in granulomatosis with polyangiitis: A general population-based study.

Zachary S Wallace1, Na Lu2, Sebastian Unizony3, John H Stone3, Hyon K Choi2.   

Abstract

BACKGROUND: Granulomatosis with polyangiitis (GPA) is associated with an increased risk of mortality; however, recent mortality trends in GPA are unknown. We evaluated this issue in a general population context.
METHODS: Using data collected between 1992 and 2013 by The Health Improvement Network in the United Kingdom, we identified individuals diagnosed as incident cases of GPA and up to 10 non-GPA controls matched on sex, age, year of birth, and year of GPA diagnosis. The cohort was divided into two based on the year of diagnosis (i.e., 1992-2002 and 2003-2013) to evaluate changes in mortality. We calculated hazard ratios for death using a Cox-proportional hazards model and the rate differences using an additive hazard model, while adjusting for potential confounders.
RESULTS: We identified 465 cases of GPA (mean age: 60 years, 52% male). The early cohort (1992-2002) GPA patients had considerably higher mortality rates than the late cohort (2003-2013) (i.e., 72.0 vs. 35.7 cases per 1000 person-years), as compared with a moderate improvement in the comparison cohorts between the two periods (19.8 vs. 17.0 cases per 1000 person-years). The corresponding absolute mortality rate difference was 52.2 (95% CI: 25.1-79.2) cases and 18.7 (95% CI: 8.3-29.1) cases per 1000 person-years (p for interaction = 0.025). The resulting HRs for mortality were 4.34 (95% CI: 2.72-6.92) and 2.41 (95% CI: 1.74-3.34), respectively (p for interaction = 0.043).
CONCLUSION: This population-based study suggests that survival of GPA patients has improved considerably over the past 2 decades, affirming the benefits of recent trends in the management of GPA and its complications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibody; Cyclophosphamide; Epidemiology; Granulomatosis with polyangiitis

Mesh:

Year:  2015        PMID: 26323883      PMCID: PMC5009368          DOI: 10.1016/j.semarthrit.2015.07.009

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  28 in total

1.  Mortality in Wegener's granulomatosis: a bimodal pattern.

Authors:  Raashid Luqmani; Ravi Suppiah; Christopher J Edwards; Rhodri Phillip; Joe Maskell; David Culliford; David Jayne; Kimberly Morishita; Nigel Arden
Journal:  Rheumatology (Oxford)       Date:  2010-11-25       Impact factor: 7.580

2.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Primary systemic vasculitis: clinical features and mortality.

Authors:  S E Lane; R A Watts; L Shepstone; D G I Scott
Journal:  QJM       Date:  2005-01-17

5.  A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis.

Authors:  Ravi Suppiah; Andrew Judge; Rajbir Batra; Oliver Flossmann; Lorraine Harper; Peter Höglund; M Kassim Javaid; David Jayne; Chetan Mukhtyar; Kerstin Westman; John C Davis; Gary S Hoffman; W Joseph McCune; Peter A Merkel; E William St Clair; Philip Seo; Robert Spiera; John H Stone; Raashid Luqmani
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

Review 6.  Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

Authors:  Anthony D Booth; Mike K Almond; Aine Burns; Peter Ellis; Gill Gaskin; Guy H Neild; Martin Plaisance; Charles D Pusey; David R W Jayne
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

7.  Survival of patients with Wegener's granulomatosis diagnosed in Finland in 1981-2000.

Authors:  J H Takala; H Kautiainen; M Leirisalo-Repo
Journal:  Scand J Rheumatol       Date:  2010       Impact factor: 3.641

8.  Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.

Authors:  P Eriksson; L Jacobsson; A Lindell; J-A Nilsson; T Skogh
Journal:  J Intern Med       Date:  2008-12-23       Impact factor: 8.989

9.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  David Jayne; Niels Rasmussen; Konrad Andrassy; Paul Bacon; Jan Willem Cohen Tervaert; Jolanta Dadoniené; Agneta Ekstrand; Gill Gaskin; Gina Gregorini; Kirsten de Groot; Wolfgang Gross; E Christiaan Hagen; Eduardo Mirapeix; Erna Pettersson; Carl Siegert; Alberto Sinico; Vladimir Tesar; Kerstin Westman; Charles Pusey
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

Review 10.  Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Authors:  C Mukhtyar; O Flossmann; B Hellmich; P Bacon; M Cid; J W Cohen-Tervaert; W L Gross; L Guillevin; D Jayne; A Mahr; P A Merkel; H Raspe; D Scott; J Witter; H Yazici; R A Luqmani
Journal:  Ann Rheum Dis       Date:  2007-10-02       Impact factor: 19.103

View more
  17 in total

1.  Granulomatosis with polyangiitis (Wegener's granulomatosis): a rare variant of sudden natural death.

Authors:  Birthe Heitkötter; Cornelius Kuhnen; Sven Schmidt; Daniel Wittschieber
Journal:  Int J Legal Med       Date:  2017-10-31       Impact factor: 2.686

2.  Epidemiology and Outcomes of Granulomatosis With Polyangiitis in Pediatric and Working-Age Adult Populations In the United States: Analysis of a Large National Claims Database.

Authors:  Sirada Panupattanapong; Dustin L Stwalley; Andrew J White; Margaret A Olsen; Anthony R French; Mary E Hartman
Journal:  Arthritis Rheumatol       Date:  2018-12       Impact factor: 10.995

3.  Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis.

Authors:  Carolyn T Thorpe; Joshua M Thorpe; Tao Jiang; Dylan Atkinson; Yihuang Kang; Loren J Schleiden; Delesha M Carpenter; Julie Anne G McGregor; Susan L Hogan
Journal:  Semin Arthritis Rheum       Date:  2017-08-10       Impact factor: 5.532

4.  Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System.

Authors:  Zachary S Wallace; Yuqing Zhang; Na Lu; John H Stone; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-09-01       Impact factor: 4.794

5.  All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.

Authors:  Zachary S Wallace; Xiaoqing Fu; Tyler Harkness; John H Stone; Yuqing Zhang; Hyon Choi
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

Review 6.  [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Authors:  Jan Henrik Schirmer; Peer M Aries; Kirsten de Groot; Bernhard Hellmich; Julia U Holle; Christian Kneitz; Ina Kötter; Peter Lamprecht; Ulf Müller-Ladner; Eva Reinhold-Keller; Christof Specker; Michael Zänker; Frank Moosig
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

7.  Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes.

Authors:  Mara Felicetti; Diego Cazzador; Roberto Padoan; Alfonso Luca Pendolino; Chiara Faccioli; Ennio Nardello; Alvise Berti; Marina Silvestrini; Giuseppe Paolazzi; Giuliano Brunori; Elisabetta Zanoletti; Enzo Emanuelli; Alessandro Martini; Franco Schiavon
Journal:  Clin Rheumatol       Date:  2018-02-20       Impact factor: 2.980

8.  Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System.

Authors:  Zachary S Wallace; Rachel Wallwork; Yuqing Zhang; Na Lu; Frank Cortazar; John L Niles; Eliot Heher; John H Stone; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2018-05-14       Impact factor: 19.103

Review 9.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

10.  The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.

Authors:  Alvise Berti; Divi Cornec; Cynthia S Crowson; Ulrich Specks; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.